Nuclear Medicine in Urinary Tract İnfection
Journal Title: Nuclear Medicine Seminars - Year 2019, Vol 5, Issue 3
Abstract
Urinary tract infections (UTIs) are frequent in pediatric population and have various clinical presentations. Definitive diagnosis is made by urinalysis and quantitative urine culture, and antibiotic treatment is usually sufficient in uncomplicated UTI cases. However, patients that have co-morbidities, congenital urinary tract anomalies, or bowel-urinary bladder dysfunction can present with recurrent infections. These patients should be investigated using renal ultrasonography, Tc-99m dimercaptosuccinic acid cortical renal scintigraphy, or voiding cystourethrography. The patient management using these imaging tools varies worldwide. This review aims to underline the strength and differences among the current guidelines on UTI.
Authors and Affiliations
Bilge Volkan Salancı
Keywords
Related Articles
- EP ID EP685337
- DOI 10.4274/nts.galenos.2019.0025
- Views 166
- Downloads 0
New Radionuclides in Pain Palliation
Skeletal system is the most common metastasis site in patients with advanced cancer. Pain is an important health problem in patients with bone metastasis. Bone seeking radionuclides to treat bone pain due to bone metasta...
Good Radiopharmacy Practices In Magistral (or Inhouse or Smallscale) Produced Radiopharmaceuticals
Radiopharmaceuticals differ from normal medicines in that they have a short half-life. Due to the rapid decay, they must be prepared shortly before their clinical use and comprehensive quality control of the final produc...
Early and Late Side Effects and Patient Management in I-131 Treatment
I-131 is the first most experienced theranostic radionuclide that has been used since the early 1940s for the treatment of hyperthyroidism, metastases or ablation of residual thyroid tissue in well-differentiated thyroid...
Good Radiopharmacy Practice (GRP): Personnel and Training
Radiopharmaceuticals are medical products that are used for diagnosis and/or treatment in humans and containing one or more radionuclides (radioisotopes). The shelf life and expiry period of the radiopharmaceutical prepa...
Quality Control of Magistral (or in House or Smallscale) Produced Radiopharmaceuticals
As it is known, magistral radiopharmaceuticals are suitable for only in house use and are prepared, produced and supplied with a medical prescription for a certain patient in good laboratory practice (GLP) standard by a...